T4GEN
Latest Information Update: 20 Feb 2008
At a glance
- Originator PharmaPrint
- Class Antineoplastics; Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; HIV infections
Most Recent Events
- 16 May 2001 No-Development-Reported for Cancer in USA (Injection)
- 16 May 2001 No-Development-Reported for HIV infections treatment in USA (Injection)
- 27 Apr 1998 Phase-I clinical trials for Cancer in USA (Injection)